AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32702879 — intervention group
Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 146
Study 36449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone dispatch of volunteer responders with instructions to retrieve nearby AEDs
Number of subjects: 947
Study 36449309 — intervention group
Group type: COMPARATOR
Intervention: Control group with instructions to go directly to OHCAs to perform CPR
Number of subjects: 947
Study 36449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall AED attachment by lay volunteers (not using the smartphone application)
Number of subjects: 947
Study 36449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteer responders using the application
Number of subjects: 947
Study 36449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall AED attachment by volunteer responders
Number of subjects: 947
Study 36449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall defibrillations by volunteer responders
Number of subjects: 947
Study 36449309 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall CPR by volunteer responders
Number of subjects: 947
Study 32966755 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant
Number of subjects: 20
Study 32966755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32423239 — intervention group
Group type: EXPERIMENTAL
Intervention: SHP465 MAS (12.5-75 mg)
Number of subjects: 438
Study 32423239 — intervention group
Group type: EXPERIMENTAL
Intervention: SHP465 MAS (25, 50, or 75 mg)
Number of subjects: 438
Study 35972853 — intervention group
Group type: COMPARATOR
Intervention: Inconsistent/nonuse of condoms
Number of subjects: 260
Study 33831097 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVS naphthalan
Number of subjects: 0
Study 33831097 — intervention group
Group type: COMPARATOR
Intervention: 0.05% betamethasone dipropionate
Number of subjects: 0
Study 34958655 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic Trabeculoplasty (PNT)
Number of subjects: 120
Study 34958655 — intervention group
Group type: COMPARATOR
Intervention: Selective Laser Trabeculoplasty (SLT)
Number of subjects: 120
Study 34958655 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PNT and SLT
Number of subjects: 120
Study 32915523 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 0
Study 32915523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35276662 — intervention group
Group type: EXPERIMENTAL
Intervention: Training Group (TG) - variable practice training with weighted wrist bands, twice a week for 1 month
Number of subjects: 34
Study 35276662 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - same number of sessions and volume of training as TG
Number of subjects: 34
Study 34548360 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical medical review with spirometry
Number of subjects: 106
Study 34548360 — intervention group
Group type: COMPARATOR
Intervention: Clinical medical review without spirometry
Number of subjects: 106
Study 36346079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg weekly for 24 weeks (group 1)
Number of subjects: 457
Study 36346079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg for 12 weeks then 150 mg for 12 weeks (group 2)
Number of subjects: 457
Study 36346079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg for 12 weeks then placebo for 12 weeks (group 3)
Number of subjects: 457
Study 36346079 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks then Bepirovirsen 300 mg for 12 weeks (group 4)
Number of subjects: 457
Study 36346079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepirovirsen (groups 1, 2, and 3)
Number of subjects: 457
Study 36346079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg weekly for 24 weeks
Number of subjects: 457
Study 35871853 — intervention group
Group type: COMPARATOR
Intervention: Tension Band Wiring (TBW)
Number of subjects: 15
Study 35871853 — intervention group
Group type: EXPERIMENTAL
Intervention: CIN with 1 conical locking screw (CIN-1)
Number of subjects: 15
Study 35871853 — intervention group
Group type: EXPERIMENTAL
Intervention: CIN with 3 conical locking screws (CIN-3)
Number of subjects: 15
Study 35871853 — intervention group
Group type: EXPERIMENTAL
Intervention: CIN-3
Number of subjects: 15
Study 34323384 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified catheterisation technique
Number of subjects: 60
Study 34323384 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheterisation
Number of subjects: 60
Study 32729802 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculated with 2×2 cm plug of 5-day-old mycelium of P. capsici
Number of subjects: 60
Study 32729802 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculated with 10 μL of zoospore suspension (2 × 105 zoospore/ml)
Number of subjects: 60
Study 32729802 — intervention group
Group type: COMPARATOR
Intervention: Control treated with sterile distilled water
Number of subjects: 60
Study 32729802 — intervention group
Group type: COMPARATOR
Intervention: Control treated with agar plug
Number of subjects: 60
Study 36153525 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR)
Number of subjects: 95
Study 36153525 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 95
Study 33030064 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation (RDN)
Number of subjects: 19
Study 33030064 — intervention group
Group type: COMPARATOR
Intervention: Drug adjustment
Number of subjects: 19
Study 36314847 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led online intervention (Harnessing Online Peer Education)
Number of subjects: 120
Study 36314847 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 33876439 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic use of RAAS blockers
Number of subjects: 1160
Study 33876439 — intervention group
Group type: COMPARATOR
Intervention: Non-use of RAAS blockers
Number of subjects: 1160
Study 34799501 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 3 mg
Number of subjects: 714
Study 34799501 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 6 mg
Number of subjects: 714
Study 34799501 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 12 mg
Number of subjects: 714
Study 34799501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 714
Study 34145121 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Balloons (PCB)
Number of subjects: 23
Study 34145121 — intervention group
Group type: COMPARATOR
Intervention: Plain Balloon Angioplasty (PTA)
Number of subjects: 23
Study 32610608 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine-Enriched Amino Acid Supplement with breakfast
Number of subjects: 46
Study 32610608 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine-Enriched Amino Acid Supplement post-exercise
Number of subjects: 46
Study 32610608 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (two sessions a day for two months)
Number of subjects: 46
Study 33526855 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Loss (WL)
Number of subjects: 177
Study 32548951 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-short (EXP-S)
Number of subjects: 67
Study 32548951 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-long (EXP-L)
Number of subjects: 67
Study 32548951 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 67
Study 32548951 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure treatments (EXP)
Number of subjects: 67
Study 36039506 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive processing therapy (CPT)
Number of subjects: 268
Study 36039506 — intervention group
Group type: COMPARATOR
Intervention: Group cognitive processing therapy (CPT)
Number of subjects: 268
Study 36039506 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual CPT
Number of subjects: 268
Study 36039506 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT (both formats)
Number of subjects: 268
Study 32175776 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive self-regulation training
Number of subjects: 0
Study 32915921 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight cycling (average number of cycles = 7.82)
Number of subjects: 2702
Study 32915921 — intervention group
Group type: EXPERIMENTAL
Intervention: Internalized weight stigma
Number of subjects: 2702
Study 34034897 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-retained removable dentures
Number of subjects: 129
Study 34034897 — intervention group
Group type: COMPARATOR
Intervention: Frequency of tooth or denture cleaning (1 time a day)
Number of subjects: 129
Study 34034897 — intervention group
Group type: COMPARATOR
Intervention: Frequency of tooth or denture cleaning (2-3 times a day)
Number of subjects: 129
Study 32492126 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 100
Study 32492126 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 100
Study 34363999 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (3 commonly prescribed antidepressants)
Number of subjects: 226
Study 34363999 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline neuroticism
Number of subjects: 226
Study 33632598 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Carbohydrate Intake (SCI)
Number of subjects: 33
Study 33632598 — intervention group
Group type: COMPARATOR
Intervention: Distributed Carbohydrate Intake (DCI)
Number of subjects: 33
Study 35179449 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed fluid intake (P-HYD)
Number of subjects: 10
Study 35179449 — intervention group
Group type: COMPARATOR
Intervention: No fluid intake (DEH)
Number of subjects: 10
Study 35179449 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum fluid intake (AL-HYD)
Number of subjects: 10
Study 35179449 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental exercise test
Number of subjects: 10
Study 35179449 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomechanical properties of the hand
Number of subjects: 10
Study 33970517 — intervention group
Group type: EXPERIMENTAL
Intervention: PTR radiomics signatures
Number of subjects: 284
Study 33970517 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated models combining PTR radiomics signature with clinical characteristics
Number of subjects: 284
Study 33970517 — intervention group
Group type: COMPARATOR
Intervention: ITR radiomics signatures
Number of subjects: 284
Study 33970517 — intervention group
Group type: COMPARATOR
Intervention: Clinical characteristics
Number of subjects: 284
Study 32988525 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% ABP
Number of subjects: 1200
Study 32988525 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.04% ABP
Number of subjects: 1200
Study 34604936 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-microgrooved implants with laser-microgrooved prosthetic abutments
Number of subjects: 20
Study 34604936 — intervention group
Group type: COMPARATOR
Intervention: Laser-microgrooved implants with machined prosthetic abutments
Number of subjects: 20
Study 32408038 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined eccentric-concentric rehabilitation (ECC-CON, n=10)
Number of subjects: 20
Study 32408038 — intervention group
Group type: COMPARATOR
Intervention: Concentric rehabilitation (CN, n=10)
Number of subjects: 20
Study 33975553 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist protocol (fresh transfer cycles)
Number of subjects: 1119
Study 33975553 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot GnRH agonist protocol (fresh transfer cycles)
Number of subjects: 1119
Study 33975553 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist protocol (frozen-thawed transfer cycles)
Number of subjects: 1119
Study 33975553 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot GnRH agonist protocol (frozen-thawed transfer cycles)
Number of subjects: 1119
Study 32108253 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar brace
Number of subjects: 50
Study 34581769 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated behavioral workplace intervention with traffic-light labeling system
Number of subjects: 397
Study 34581769 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 397
Study 34581769 — intervention group
Group type: COMPARATOR
Intervention: Baseline comparison between Q4 and Q1
Number of subjects: 397
Study 34581769 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month follow-up comparison between Q4 and Q1
Number of subjects: 397
Study 34581769 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-month follow-up comparison between Q4 and Q1
Number of subjects: 397
Study 34581769 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 397
Study 33929343 — intervention group
Group type: EXPERIMENTAL
Intervention: Culprit-only revascularization strategy
Number of subjects: 0
Study 33929343 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from medical contact to revascularization
Number of subjects: 0
Study 33929343 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial vascular access
Number of subjects: 0
Study 33929343 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initialization of mechanical circulatory support
Number of subjects: 0
Study 34273604 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxification for one month
Number of subjects: 60
Study 34273604 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxification for three months
Number of subjects: 60
Study 34273604 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxification for six months
Number of subjects: 60
Study 34273604 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 healthy women)
Number of subjects: 60
Study 32210475 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives
Number of subjects: 0
Study 33302704 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal and social rhythm therapy (with or without cognitive remediation)
Number of subjects: 20
Study 32047951 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab followed by alendronate
Number of subjects: 275
Study 32047951 — intervention group
Group type: COMPARATOR
Intervention: Alendronate alone
Number of subjects: 275
Study 35937566 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam besylate
Number of subjects: 75
Study 35937566 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 75
Study 33065120 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 6 g
Number of subjects: 17400
Study 33065120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17400
Study 32070309 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemoradiotherapy (POCRT) with 50.4 Gy concurrent with paclitaxel (135-150 mg/m2) plus cisplatin or nedaplatin (50-75 mg/m2) every 28 days for two cycles.
Number of subjects: 120
Study 32070309 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (PORT) with a prescription dose of 54 Gy.
Number of subjects: 120
Study 32070309 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (SA).
Number of subjects: 120
Study 616737893 — intervention group
Group type: EXPERIMENTAL
Intervention: DIME expert‐supervised (DES) group
Number of subjects: 1313
Study 616737893 — intervention group
Group type: COMPARATOR
Intervention: DIME cadre‐supervised (DCS) group
Number of subjects: 1313
Study 36228406 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi intervention (8 weeks)
Number of subjects: 72
Study 36228406 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care only)
Number of subjects: 72
Study 33571868 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivacaftor (28 days)
Number of subjects: 20
Study 33571868 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label extension (5 months)
Number of subjects: 20
Study 33571868 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline to end of open-label extension
Number of subjects: 20
Study 33571868 — intervention group
Group type: COMPARATOR
Intervention: Placebo (28 days)
Number of subjects: 20
Study 33571868 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up (2 years)
Number of subjects: 20
Study 32522125 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein and energy supplementation (Atole)
Number of subjects: 0
Study 32522125 — intervention group
Group type: COMPARATOR
Intervention: No protein and low energy supplementation (Fresco)
Number of subjects: 0
Study 35324270 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilar pegfilgrastim (PegFilBS)
Number of subjects: 120
Study 35324270 — intervention group
Group type: COMPARATOR
Intervention: Originator pegfilgrastim (PegFilOR)
Number of subjects: 120
Study 35398370 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention (individual clinic visits)
Number of subjects: 1177
Study 35398370 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention (other unspecified arms)
Number of subjects: 1177
Study 35878838 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 40
Study 35878838 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study 35229777 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion + resin infiltration (fluorosis with stains)
Number of subjects: 120
Study 35229777 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion + remineralization (fluorosis with stains)
Number of subjects: 120
Study 35229777 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion + resin infiltration (fluorosis without stains)
Number of subjects: 120
Study 35229777 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion + remineralization (fluorosis without stains)
Number of subjects: 120
Study 35229777 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration
Number of subjects: 120
Study 35229777 — intervention group
Group type: COMPARATOR
Intervention: Remineralization
Number of subjects: 120
Study 33849104 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention during the perioperative period
Number of subjects: 92
Study 33140981 — intervention group
Group type: EXPERIMENTAL
Intervention: reSET-O PDT
Number of subjects: 3144
Study 33140981 — intervention group
Group type: EXPERIMENTAL
Intervention: reSET-O PDT (subgroup analysis)
Number of subjects: 3144
Study 33153439 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz vibration therapy for 20 weeks, 9 min per day, 4 times a week
Number of subjects: 0
Study 33153439 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 Hz vibration therapy for 20 weeks, 9 min per day, 4 times a week
Number of subjects: 0
Study 33153439 — intervention group
Group type: COMPARATOR
Intervention: Control group (12-week lead-in period prior to intervention)
Number of subjects: 0
Study 34706567 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl lavage
Number of subjects: 96
Study 34706567 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline solution
Number of subjects: 96
Study 34706567 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9/TP levels
Number of subjects: 96
Study 34706567 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl lavage
Number of subjects: 96
Study 34526100 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES plus standard care
Number of subjects: 58
Study 34526100 — intervention group
Group type: COMPARATOR
Intervention: Sham-NMES plus standard care
Number of subjects: 58
Study 32527349 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum air leakage method
Number of subjects: 100
Study 32527349 — intervention group
Group type: COMPARATOR
Intervention: Cuff pressure manometer method
Number of subjects: 100
Study 35247334 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical LHA510 (twice a day for 8 weeks, then 3 times a day for 4 weeks)
Number of subjects: 90
Study 35247334 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 90
Study 33054121 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib 160 mg twice daily
Number of subjects: 109
Study 35430026 — intervention group
Group type: EXPERIMENTAL
Intervention: Alloderm group (n=30)
Number of subjects: 60
Study 35430026 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=30)
Number of subjects: 60
Study 33181659 — intervention group
Group type: EXPERIMENTAL
Intervention: Hominis placenta pharmacopuncture
Number of subjects: 30
Study 33181659 — intervention group
Group type: COMPARATOR
Intervention: Saline pharmacopuncture (Control)
Number of subjects: 30
Study 34013542 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-applied transcutaneous electrical nerve stimulation (TENS) device
Number of subjects: 74
Study 34013542 — intervention group
Group type: COMPARATOR
Intervention: Sham group (active placebos)
Number of subjects: 74
Study 32623673 — intervention group
Group type: COMPARATOR
Intervention: 100% DW
Number of subjects: 4
Study 32623673 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% TGW + 75% DW
Number of subjects: 4
Study 32623673 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% TGW + 50% DW
Number of subjects: 4
Study 32623673 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% TGW + 25% DW
Number of subjects: 4
Study 32623673 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% TGW
Number of subjects: 4
Study 36180101 — intervention group
Group type: EXPERIMENTAL
Intervention: IFX‐qbtx (3 mg/kg intravenous at weeks 0, 2 and 6, then every 8 weeks)
Number of subjects: 1247
Study 36180101 — intervention group
Group type: COMPARATOR
Intervention: IFX‐EU (3 mg/kg intravenous at weeks 0, 2 and 6, then every 8 weeks)
Number of subjects: 1247
Study 36180101 — intervention group
Group type: EXPERIMENTAL
Intervention: ADL‐afzb (40 mg subcutaneous every other week)
Number of subjects: 1247
Study 36180101 — intervention group
Group type: COMPARATOR
Intervention: ADL‐EU (40 mg subcutaneous every other week)
Number of subjects: 1247
Study 34346266 — intervention group
Group type: EXPERIMENTAL
Intervention: IND/MF high-dose (150/320 μg)
Number of subjects: 323
Study 34346266 — intervention group
Group type: EXPERIMENTAL
Intervention: IND/MF medium-dose (150/160 μg)
Number of subjects: 323